Virus-specific activated T lymphocytes (donor-derived)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Virus-specific activated T lymphocytes (donor-derived), covering 2024-01-24 to 2024-01-24. Get the full timeline:
Most recent: Clinical Trial Update: Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients [Phase 1, Phase 2]